Hepatolite Disease Interactions
There is 1 disease interaction with Hepatolite (disofenin).
Technetium Tc 99m disofenin/mebrofenin (applies to Hepatolite) gallbladder nonvisualization
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Pancreatitis, Liver Disease, Sepsis, Biliary Obstruction
Nonvisualization or delayed visualization of the gallbladder may occur in certain populations, including patients who have been fasting for a prolonged period or undergoing parenteral feeding; patients with chronic cholecystitis or pancreatitis; and patients with hepatocellular disease or juvenile hepatitis. Septic patients may show absent or delayed hepatobiliary clearance. Therefore, a positive finding does not, by itself, permit a differential diagnosis and should be considered in conjunction with the total clinical picture and results of other diagnostic modalities.
References (1)
- (2012) "Product Information. Choletec (mebrofenin)." Bracco Diagnostics Inc
Switch to consumer interaction data
More about Hepatolite (disofenin)
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.